Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1858 ARTÍCULOS , VIENDO DEL 1231 AL 1245

The effect of insomnia on development of Alzheimer's disease

Sadeghmousavi S, Eskian M, Rahmani F, Rezaei N.

J Neuroinflammation. 2020 Oct 6;17(1):289. doi: 10.1186/s12974-020-01960-9.

Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop

Zlokovic BV, Gottesman RF, Bernstein KE, Seshadri S, McKee A, Snyder H, Greenberg SM, Yaffe K, Schaffer CB, Yuan C, Hughes TM, Daemen MJ, Williamson JD, González HM, Schneider J, Wellington CL, Katusic ZS, Stoeckel L, Koenig JI, Corriveau RA, Fine L, Galis ZS, Reis J, Wright JD, Chen J.

Alzheimers Dement. 2020 Dec;16(12):1714-1733. doi: 10.1002/alz.12157. Epub 2020 Oct 8.

Does Mild Traumatic Brain Injury Increase the Risk for Dementia? A Systematic Review and Meta-Analysis

Snowden TM, Hinde AK, Reid HMO, Christie BR.

J Alzheimers Dis. 2020;78(2):757-775. doi: 10.3233/JAD-200662.

Anti-Aβ agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis

Lu L, Zheng X, Wang S, Tang C, Zhang Y, Yao G, Zeng J, Ge S, Wen H, Xu M, Guyatt G, Xu N.

J Neurol Neurosurg Psychiatry. 2020 Dec;91(12):1316-1324. doi: 10.1136/jnnp-2020-323497. Epub 2020 Oct 12.

Psychosis in Alzheimer's Disease

Ballard C, Kales HC, Lyketsos C, Aarsland D, Creese B, Mills R, Williams H, Sweet RA.

Curr Neurol Neurosci Rep. 2020 Oct 13;20(12):57. doi: 10.1007/s11910-020-01074-y.

Uptake and effectiveness of a tailor-made online lifestyle programme targeting modifiable risk factors for dementia among middle-aged descendants of people with recently diagnosed dementia: study protocol of a cluster randomised controlled trial (Demin study)

Vrijsen J, Abu-Hanna A, Maeckelberghe EL, De Deyn PP, de Winter AF, Reesink FE, Oude Voshaar RC, Buskens E, de Rooij SE, Smidt N; Demin consortium.

BMJ Open. 2020 Oct 16;10(10):e039439. doi: 10.1136/bmjopen-2020-039439.

Dietary Fatty Acid Factors in Alzheimer's Disease: A Review

Zhang T, Han X, Zhang X, Chen Z, Mi Y, Gou X.

J Alzheimers Dis. 2020;78(3):887-904. doi: 10.3233/JAD-200558.

Acute versus Chronic Exposures to Inhaled Particulate Matter and Neurocognitive Dysfunction: Pathways to Alzheimer's Disease or a Related Dementia

Kritikos M, Gandy SE, Meliker JR, Luft BJ, Clouston SAP.

J Alzheimers Dis. 2020;78(3):871-886. doi: 10.3233/JAD-200679.

Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial

Gibson GE, Luchsinger JA, Cirio R, Chen H, Franchino-Elder J, Hirsch JA, Bettendorff L, Chen Z, Flowers SA, Gerber LM, Grandville T, Schupf N, Xu H, Stern Y, Habeck C, Jordan B, Fonzetti P.

J Alzheimers Dis. 2020;78(3):989-1010. doi: 10.3233/JAD-200896.

Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia

Matias-Guiu JA, Pytel V, Matías-Guiu J.

J Alzheimers Dis. 2020;78(2):537-541. doi: 10.3233/JAD-200940.

Cross-sectional associations of amyloid burden with semantic cognition in older adults without dementia: A systematic review and meta-analysis

Vonk JMJ, Twait EL, Scholten RJPM, Geerlings MI.

Mech Ageing Dev. 2020 Dec;192:111386. doi: 10.1016/j.mad.2020.111386. Epub 2020 Oct 19.

Ganglion Cell Layer Thinning in Alzheimer's Disease

López-de-Eguileta A, Cerveró A, Ruiz de Sabando A, Sánchez-Juan P, Casado A.

Medicina (Kaunas). 2020 Oct 21;56(10):553. doi: 10.3390/medicina56100553.

Randomized Controlled Trial of Multi-Component Cognitive Stimulation Therapy (SADEM) in Community-Dwelling Demented Adults

Juárez-Cedillo T, Gutiérrez-Gutiérrez L, Sánchez-Hurtado LA, Martínez-Rodríguez N, Juarez-Cedillo E.

J Alzheimers Dis. 2020;78(3):1033-1045. doi: 10.3233/JAD-200574.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias